These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 39126093)

  • 21. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
    Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
    Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palladium and platinum complexes based on pyridine bases induced anticancer effectiveness via apoptosis protein signaling in cancer cells.
    El-Bendary MM; Akhdhar A; Al-Bogami AS; Domyati D; Kalantan AA; Alzahrani FA; Alamoudi SM; Sheikh RA; Ali EMM
    Biometals; 2024 Aug; 37(4):905-921. PubMed ID: 38361146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water-Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands.
    Ali A; Stefàno E; De Castro F; Ciccarella G; Rovito G; Marsigliante S; Muscella A; Benedetti M; Fanizzi FP
    Chemistry; 2024 Jul; 30(38):e202401064. PubMed ID: 38703115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization, and biological activity of platinum II, III, and IV pivaloamidine complexes.
    Sinisi M; Gandin V; Saltarella T; Intini FP; Pacifico C; Marzano C; Natile G
    J Biol Inorg Chem; 2014 Oct; 19(7):1081-97. PubMed ID: 24850131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative assessment of the cytotoxic effects of carboxylato-bridged dinuclear platinum (II) complexes against human tumor cell lines.
    Momekov G; Bakalova A; Konstantinov S; Todorov D; Karaivanova M
    Neoplasma; 2005; 52(6):469-75. PubMed ID: 16284691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor potential of platinum(II) complexes of selenium donor ligands.
    Ahmad S; Isab AA; Al-Arfaj AR
    Metallomics; 2023 Apr; 15(4):. PubMed ID: 36918206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of the anticancer activity of [Pt(diimine)(N,N-dibutyl-N'-acylthiourea)]
    Peega T; Magwaza RN; Harmse L; Kotzé IA
    Dalton Trans; 2021 Sep; 50(34):11742-11762. PubMed ID: 34369524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, biological evaluation and SAR studies of novel bicyclic antitumor platinum(IV) complexes.
    Lorenzo J; Delgado A; Montaña ÁM; Mesas JM; Alegre MT; Rodríguez Mdel C; Avilés FX
    Eur J Med Chem; 2014 Aug; 83():374-88. PubMed ID: 24980119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents.
    Wang Q; Huang Z; Ma J; Lu X; Zhang L; Wang X; George Wang P
    Dalton Trans; 2016 Jun; 45(25):10366-74. PubMed ID: 27252024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Biological Studies on Dinuclear Gold(I) Complexes with Di-(
    Tresin F; Stoppa V; Baron M; Biffis A; Annunziata A; D'Elia L; Monti DM; Ruffo F; Roverso M; Sgarbossa P; Bogialli S; Tubaro C
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32847116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential.
    Leal J; Santos L; Fernández-Aroca DM; Cuevas JV; Martínez MA; Massaguer A; Jalón FA; Ruiz-Hidalgo MJ; Sánchez-Prieto R; Rodríguez AM; Castañeda G; Durá G; Carrión MC; Barrabés S; Manzano BR
    J Inorg Biochem; 2021 May; 218():111403. PubMed ID: 33730639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
    Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
    Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells
    Petrovic M; Popovic S; Baskic D; Todorovic M; Djurdjevic P; Ristic-Fira A; Keta O; Petkovic V; Koricanac L; Stojkovic D; Jevtic V; Trifunovic S; Todorovic D
    Anticancer Res; 2020 Sep; 40(9):5001-5013. PubMed ID: 32878788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, antiproliferative activity and DNA binding study of mixed ammine/cyclohexylamine platinum(II) complexes with 1-(substituted benzyl) azetidine-3, 3-dicarboxylates.
    Sun Y; Gou S; Yin R; Jiang P
    Eur J Med Chem; 2011 Oct; 46(10):5146-53. PubMed ID: 21875765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, cytotoxicity, and apoptosis induction study of antitumor dinuclear platinum(II) complexes.
    Xu G; Gou S; Gao C
    Arch Pharm (Weinheim); 2013 Apr; 346(4):308-13. PubMed ID: 23447402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
    Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
    Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Influence of the Auxiliary Ligand in Monofunctional Pt(II) Anticancer Complexes on the DNA Backbone.
    Tagari EV; Sifnaiou E; Tsolis T; Garoufis A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions.
    Wei ZZ; Qin QP; Meng T; Deng CX; Liang H; Chen ZF
    Eur J Med Chem; 2018 Feb; 145():360-369. PubMed ID: 29335202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of bridging ligands in determining DNA-binding ability and cross-linking patterns of dinuclear platinum(II) antitumour complexes.
    Zhu J; Lin M; Fan D; Wu Z; Chen Y; Zhang J; Lu Y; Guo Z
    Dalton Trans; 2009 Dec; (48):10889-95. PubMed ID: 20023919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.